We are live on
!
Find out more
GA
Geneva Advisors Portfolio holdings
AUM
$5.81B
Turnover
22.5%
1-Year Est. Return
23.71%
This Fund
S&P 500
This Quarter
Est. Return
+1.09%
1 Year Est. Return
+23.71%
3 Year Est. Return
+53.12%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$5.6B
AUM Growth
+$69.6M
(+1.3%)
Cap. Flow
+$51.5M
Cap. Flow
% of AUM
0.92%
Top 10 Holdings %
Top 10 Hldgs %
21.06%
Holding
781
New
66
Increased
297
Reduced
239
Closed
62
Avg Time Held
1.3
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
0.8
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
TD Ameritrade Holding Corp
AMTD
|
+$41.7M |
| 2 |
LyondellBasell Industries
LYB
|
+$33.9M |
| 3 |
Brookfield
BN
|
+$27.6M |
| 4 |
CONE
CyrusOne Inc Common Stock
CONE
|
+$21.4M |
| 5 |
Becton Dickinson
BDX
|
+$20.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Polaris
PII
|
+$36M |
| 2 |
T. Rowe Price
TROW
|
+$31.5M |
| 3 |
Elevance Health
ELV
|
+$27.8M |
| 4 |
ITC
ITC HOLDINGS CORP
ITC
|
+$26.5M |
| 5 |
Applied Materials
AMAT
|
+$24.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Financials | 18.2% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Technology | 11.08% |
| 5 | Industrials | 10.88% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
476
Parker-Hannifin
PH
$121B
| $286K | 0.01% |
+2,460
| New | +$297K |
2015 Q2
0 quarters
|
|
477
Range Resources
RRC
$9.68B
| $285K | 0.01% |
5,780
+540
| +10% | +$30.8K |
2013 Q2
8 quarters
|
|
478
Celldex Therapeutics
CLDX
$2.27B
| $283K | 0.01% |
749
+237
| +46% | +$94.1K |
2015 Q1
1 quarter
|
|
479
Tenaris
TS
$28.9B
| $283K | 0.01% |
10,479
-357
| -3% | -$10.6K |
2014 Q1
5 quarters
|
|
|
HZNP
480
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $283K | 0.01% |
8,150
| – | – |
2013 Q3
7 quarters
|
|
481
RLI Corp
RLI
$5.46B
| $281K | 0.01% |
10,948
| – | – |
2014 Q4
2 quarters
|
|
482
Schwab US Large- Cap ETF
SCHX
$74.6B
| $278K | 0.01% |
33,882
| – | – |
2014 Q1
5 quarters
|
|
483
Target
TGT
$71.2B
| $275K | ﹤0.01% |
3,368
+430
| +15% | +$34.8K |
2013 Q2
8 quarters
|
|
484
State Street Technology Select Sector SPDR ETF
XLK
$125B
| $275K | ﹤0.01% |
13,304
+278
| +2% | +$5.93K |
2014 Q1
5 quarters
|
|
485
Nucor
NUE
$57.8B
| $274K | ﹤0.01% |
+6,213
| New | +$298K |
2015 Q2
0 quarters
|
|
486
Citigroup
C
$207B
| $267K | ﹤0.01% |
4,828
-475
| -9% | -$25.8K |
2013 Q2
8 quarters
|
|
487
AptarGroup
ATR
$7.9B
| $265K | ﹤0.01% |
4,154
| – | – |
2013 Q2
8 quarters
|
|
488
Dominion Energy
D
$55.3B
| $263K | ﹤0.01% |
3,940
-250
| -6% | -$17.6K |
2013 Q4
6 quarters
|
|
489
Paychex
PAYX
$39.4B
| $263K | ﹤0.01% |
5,602
+144
| +3% | +$7.04K |
2014 Q1
5 quarters
|
|
490
Distribution Solutions Group
DSGR
$1.62B
| $260K | ﹤0.01% |
22,136
| – | – |
2013 Q2
8 quarters
|
|
491
iShares S&P Mid-Cap 400 Value ETF
IJJ
$8.53B
| $259K | ﹤0.01% |
4,016
| – | – |
2014 Q1
5 quarters
|
|
492
TransDigm Group
TDG
$62.7B
| $259K | ﹤0.01% |
1,154
-30
| -3% | -$6.72K |
2013 Q2
8 quarters
|
|
493
Oxford Lane Capital
OXLC
$820M
| $258K | ﹤0.01% |
3,630
| – | – |
2013 Q3
7 quarters
|
|
494
DELISTED
PUBLIC STORAGE DEPOSITARY REPSTG PFD SER X (MD)
PSA.PRX
| $258K | ﹤0.01% |
11,000
-1,000
| -8% | -$23.5K |
2014 Q1
5 quarters
|
|
|
495
DELISTED
Public Storage Depositary Shares, Each Representing 1/1,000 of a 5.20% Cumulative Preferred Share of
PSA.PRW
| $256K | ﹤0.01% |
11,000
-4,000
| -27% | -$95.9K |
2014 Q3
3 quarters
|
|
496
Universal Display
OLED
$3.6B
| $255K | ﹤0.01% |
4,935
| – | – |
2015 Q1
1 quarter
|
|
|
BBBY
497
DELISTED
Bed Bath & Beyond Inc
BBBY
| $255K | ﹤0.01% |
3,700
+300
| +9% | +$21.5K |
2014 Q3
3 quarters
|
|
|
DISCK
498
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $254K | ﹤0.01% |
8,170
-410
| -5% | -$12.7K |
2014 Q3
3 quarters
|
|
499
State Street Materials Select Sector SPDR ETF
XLB
$7.99B
| $251K | ﹤0.01% |
10,376
-7,942
| -43% | -$200K |
2014 Q2
4 quarters
|
|
|
SYT
500
DELISTED
Syngenta Ag
SYT
| $251K | ﹤0.01% |
+3,070
| New | +$247K |
2015 Q2
0 quarters
|
|
Similar funds
CAM
DL
TCM
HCM
AL
AT
Geneva Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, Geneva Advisors held 781 positions worth $5.6B, up 1.3% from $5.53B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Geneva Advisors's Q2 2015 filing shows 66 new, 297 increased, 239 reduced and 62 closed positions. Its largest new stake was LinkedIn Corporation: 75,249 shares worth $15.5M. The largest sale was Polaris, an estimated $36M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 19% a quarter earlier, followed by Financials and Consumer Discretionary.
- Geneva Advisors's largest Q2 2015 buy was LinkedIn Corporation: 75,249 shares worth $15.5M.
- Geneva Advisors added most to TD Ameritrade Holding Corp in Q2 2015, an estimated $41.7M increase.
- Geneva Advisors's biggest Q2 2015 reduction was Polaris, cutting an estimated $36M.
- Geneva Advisors fully exited Applied Materials in Q2 2015, selling an estimated $24.6M.
- Geneva Advisors's ten largest holdings make up 21% of its $5.6B portfolio in Q2 2015.
- Geneva Advisors opened 66 new positions and closed 62 in Q2 2015.
- Geneva Advisors's portfolio value rose 1.3% quarter-over-quarter to $5.6B.
Based on Geneva Advisors's 13F filing for Q2 2015, filed 3 Aug 2015.